Rs 80.2 10 % Off
Package size
Estimate Delivery by:
Delivering to
Easy 7 days return available
Kofwiz LS 1mg Syrup is used to relieve symptoms of asthma and chronic obstructive pulmonary disease (COPD), such as coughing, wheezing, and breathlessness. It helps relax the muscles of the air passages, widening them and making breathing easier. You can take Kofwiz LS 1mg Syrup with or without food. The dose will depend on the severity of your condition and how you respond to the medicine. Try to take it at the same time each day. It is important to keep taking this medicine until your doctor tells you not to. Use this medicine regularly to get the most benefit, even if you feel well. Kofwiz LS 1mg Syrup is generally safe and effective, but some common side effects include tremor, headache, and increased heart rate. These side effects are not often dangerous, and they should gradually improve as your body gets used to this medicine. There are other, rarer, side effects, and you should call your doctor straight away if you get chest pain, a very bad headache, or very bad dizziness. Before using Kofwiz LS 1mg Syrup, tell your doctor if you have high blood pressure, an overactive thyroid gland, a history of heart problems, diabetes, or low potassium levels in your blood, to make sure it is safe. Also, make sure your doctor knows if you are pregnant or breastfeeding before taking this medicine. Because this medicine can make you feel dizzy or shaky, do not drive, cycle, or use tools or machinery until you feel better. You should not smoke as it causes damage to your lungs and will make your condition worse.
Uses: Asthma | Chronic obstructive pulmonary disease (COPD) Benefits: Asthma Asthma is a chronic condition where the airways in the lungs become inflamed and narrowed, leading to symptoms such as wheezing, breathlessness, coughing, and chest tightness. Kofwiz LS 1mg Syrup helps by relaxing the airway muscles, making it easier to breathe. It provides quick relief from asthma symptoms and improves the ability to carry out daily activities without respiratory discomfort. Chronic obstructive pulmonary disease (COPD) Chronic obstructive pulmonary disease (COPD) is a progressive lung disease that includes conditions like chronic bronchitis and emphysema, which cause airflow limitation and breathing difficulties. Kofwiz LS 1mg Syrup works by opening up the airways and easing airflow, helping patients breathe more comfortably. It reduces the frequency and severity of breathlessness episodes, enabling better exercise tolerance and improving overall respiratory quality of life.
Kofwiz LS 1mg Syrup is a bronchodilator. It works by relaxing the muscles in the airways and widens airways. This makes breathing easier.
Take this medicine in the dose and duration as advised by your doctor. Check the label for directions before use. Measure it with a measuring cup and take it by mouth. Shake well before use. Kofwiz LS 1mg Syrup may be taken with or without food.
Safety Advice: Alcohol: Alcohol should be used with caution while taking Kofwiz LS 1mg Syrup. Pregnancy: The safety of Kofwiz LS 1mg Syrup during pregnancy has not been established. There are no adequate and well-controlled studies in pregnant women, and animal data on reproductive toxicity are insufficient. Your doctor will weigh the benefits and any potential risks before prescribing. Breast feeding: Available human data suggest that the drug does not pass into breast milk in clinically significant amounts and is unlikely to harm the infant. Driving: Kofwiz LS 1mg Syrup may decrease alertness, affect your vision, or make you feel sleepy and dizzy. Do not drive if these symptoms occur. Kidney: Kofwiz LS 1mg Syrup should be used with caution in patients with kidney disease. Dose adjustment may be needed. Liver: Kofwiz LS 1mg Syrup is probably safe to use in patients with liver disease. Limited data suggest dose adjustment may not be needed. Side Effects: Tremors | Headache | Increased heart rate | Nausea
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s